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Abstract
Background: Formation of  Malondialdehyde (MDA), a free radical, in Tuberculosis patients does occur when Tubercule 
bacilli induces reactive oxygen species as a result of  phagocytic respiratory burst.
Objectives: This study evaluated the effect of  treatment on plasma level of  Malondialdehyde among patients infected with 
Mycobacterium Tuberculosis in Osogbo South Western Nigeria. 
Methodology: Descriptive cross sectional study among 110 patients, grouped into four categories (three TB patient cate-
gories and controls). All patients were screened for presence or absence of  Mycobacterium tuberculosis in their sputum and 
HIV 1 & 2 in their blood using standard techniques. The level of  free radical (Malondialdehyde, MDA) was determined by 
Thiobabituric acid reacting method. Data was analyzed using the SPSS software version 17.0
Results: Serum Malondialdehyde (MDA) levels were significantly lower in TB patients on drugs (TBD) compared with the 
new cases on treatment (NCT). (0.17+0.88mol/L Vs 0.27+0.08mol/L, p<0.05). Varying degrees of  correlations were also 
found between free radicals and electrolytes. 
Conclusion: Reduced serum MDA levels in TBD suggested a reduction in the levels of  free radical injury once treatment 
was commenced. Therefore serum free radical may be an index of  monitoring response to treatment in tuberculosis man-
agement. 
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electrolytes.
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Introduction
Tuberculosis (TB) is a re-emerging disease which infects 
about one-third of  the world's current population, with 
new infections occurring at a rate of  one per second.1,2 
TB is one of  the few diseases for which specific control 
targets have been set in the Millennium Development 
Goals. It has been recognized to be associated with a 
degree of  compromise of  the immune system, particu-
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larly failing cytokine responses and overproduction of  
IL-10 and TGFß.3 This is coupled with the involvement 
of  different T- lymphocytes in immune response against 
M. tuberculosis,4 but production of  interferon-gamma 
(IFN-gamma) by T cells seems to be fundamental for 
disease control.5 
The stimulation of  the immune system is caused by 
an increase in free radical production as a result of  in-
crease in phagocytosis. Antioxidants neutralize the free 
radicals and protect the body from the damaging effects 
of  these free radicals. Mycobacteria can induce reactive 
oxygen species (ROS) production by activating phago-
cytes. Although this is an important part of  the host de-
fense against Mycobacteria, enhanced ROS generation 
may promote tissue injury and inflammation. This may 
further contribute to immune-suppression particularly 
in those with impaired antioxidant capacity, such as in 
HIV infected patients.6
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The functional changes in hyper-activated macrophages 
manifest themselves in their ability to destroy the in-
tracellular micro-organism (Tubercle bacilli). Whenever 
phagocytosis by activated macrophages fails, hydrogen 
peroxide (H202) is released. This Hydrogen peroxide 
(H2O2) is released continually by the macrophages with 
a resultant high free radical load in pulmonary TB cli-
ents.7 Furthermore, during pulmonary inflammation, 
increased amounts of  ROS and reactive nitrogen in-
termediates (RNI) are produced as a consequence of  
phagocytic respiratory burst.
TB is the most common opportunistic infection and 
the single most common cause of  death among HIV 
infected people in Africa today.8 Latent TB infection 
has been known to revert to active TB following new 
infection in HIV infected people. TB has been shown 
to accelerate the progression of  HIV disease. These ep-
idemiologic relationships between TB and HIV, and the 
high prevalence of  these diseases in sub-Saharan Africa 
and indeed Nigeria make studying TB and HIV infected 
populations in this region of  the world important. The 
malnutrition which is commonly present in patients 
with tuberculosis can add to the impaired antioxidant 
capacity in these patients.
This study determined the plasma levels of  Malon-
dialdehyde; a product in patients with pulmonary tu-
berculosis, those with HIV co-infection, and those on 
treatment. Comparing free radicals level in controls and 
various categories of  TB patients would go a long way 
in addressing challenges connected with some of  the 
associated electrolyte imbalance from sources such as 
diarrhea, vomiting and excessive sweating. The overall 
objective of  this study was to determine the effect of  




Study location: This study was conducted in Osogbo, 
an ancient city of  approximately 625,000 people based 
on the last Nigerian census data.9 It is located in the 
heart of  SouthWestern Nigerian’s Yoruba speaking 
people and covers about 300sq Km2. Osogbo with two 
local governments is served by a secondary, a tertiary 
and numerous Primary Health Care facilities. There is a 
non-governmental organization (Damien Foundation) 
working in the area of  TB and HIV in the city. The 
prevalence of  TB in the city is not readily available; 
HIV prevalence in the city was 2.9%, which is a bit low-
er than the national average of  4.1%.10
Study design: This was a hospital-based cross-section-
al study among various categories of  TB infected pat-
ents.
Study population: There were 4 categories of  patients 
recruited from four TB management centers in Osog-
bo namely Sabo Primary Health Centre, Oke-Baale Pri-
mary Health Centre, Osun State University Teaching 
Hospital,Asubiaro and Ladoke Akintola University of  
Technology Teaching Hospital, Osogbo. The categories 
were;
(a)    Group 1: 50 normal patients without TB or HIV 
in the sex ratio of  1:1
(b)    Group 2: 20 new positive cases of  Mycobacterium 
tuberculosis patients without HIV in the ratio of   male/
female of  2:1
(c)    Group 3: 20 new positive cases of  tuberculosis 
co-infected with HIV in a sex ratio of  1:1
(d)   Group 4: 20 positive cases of  Mycobacterium tu-
berculosis patients on anti tuberculous drugs consisting 
of  11 males and 09 females. 
Ethical approval: The study received approval of  the 
Research Ethical Review Committee of  LAUTECH 
Teaching Hospital Osogbo, and the permission of  the 
management of  the different health facilities. Written 
informed consent was sought and obtained from each 
patient after the study had been explained to them.
Sampling procedure: A total of  one hundred and ten 
patients participated in this study. Every new case was 
screened for Mycobacterium tuberculosis in their spu-
tum using Zielh-Neelsen modified technique. The pres-
ence or absence of  HIV in their blood was detected by 
using the national algorithm for the diagnosis of  HIV 
(Determine-Unigold-Start-pack Kits). Determine™ 
HIV-1/2 kits used were manufactured by Inverse Med-
ical Technical Specialist Laboratory, UK. The fifty (50) 
controls for this study were recruited among volunteers 
who were on routine medical check-up at the teaching 
hospital. These were matched for age with the cases. 
They were also screened for HIV and pulmonary TB 
and confirmed negative.
Exclusion criteria: Patients with symptoms of  malaria 
fever, Diabetes Mellitus, patients with intestinal infec-
tions which could lead to dysentery, women using con-
traceptives, patients on corticosteroids therapy, preg-
nant women and patients with symptoms of  jaundice, 
chronic obstructive pulmonary diseases, cancers and 
other chronic illnesses were excluded from this study.
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Treatment: After their tuberculosis was diagnosed, pa-
tients were commenced on Anti-TB drugs of  Directly 
Observed Treatment–Short course (DOTS) according 
to National guidelines on treatment of  TB and TB and 
HIV co-infection.9 All cases were managed by the at-
tending TB Physicians.
Blood and sputum sample collection
Five to seven millimeters of  venous blood was obtained 
from the cubital vein of  each subject using a sterile nee-
dle and syringe into a lithium heparin bottle. The plas-
ma was extracted by centrifugation for 10 minutes at 
4000rpm into a plain bottle and stored at -200C until the 
time of  analysis for electrolytes and free radicals. The 
sputum of  patients (except those on anti-tuberculosis 
drugs) and controls were collected into sterile universal 
bottles for Ziehl-Nelseen staining.
Biochemical analysis
Estimation of  Free Radical: using Thiobarbituric 
acid reacting method was based on the principle that 
Trichloroacetic acid (TCA) precipitates protein and 
thiobabituric acid reacts with Malondialdehyde (MDA) 
to give a red coloured complex that is read spectropho-
tometrically at 532nm.11
Estimation of  electrolytes levels: Sodium and Po-
tassium were estimated using Flame emission spectro-
photometry method.11 Chloride was estimated using 
Colorimetric: TPTZ [Mercury (II)-2,4,6-tri-(2-pyridyl)-




Data management: Data was entered into the com-
puter and analyzed using the SPSS software version 17.0 
Validity of  data entered was further ensured through 
double entry of  data and random checks. Frequency ta-
bles were generated and mean values were calculated.
 
Results
Figure I is a pie chart showing the frequency and per-
centage distribution of  the study population. The test 
groups comprised of  three (3) groups; the first group 
being the new cases and made up of  20 patients (18.18% 
of  the total population) who were not on drugs. The 
second group comprising of  20 patients who had been 
on drugs for 5-6weeks (18.18% of  the total population) 
while the third group were those having co-infection 
with HIV. They were also made up 20 patients and were 
not on drugs (18.18% of  the total population). The 
control group was of  50 patients (45.45% of  the total 
population)
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Biochemical parameters: In Table I, The free radi-
cals were significantly lower in control patients when 
compared with total subject population, new case TB 
patients, and TB co-infection with HIV (0.17±0.90 Vs 
0.25±0.11, 0.27±0.08, 0.30±1.45 µmol/L; P<0.05). 
However, a slight significantly higher mean value was 
observed in the controls when compared with TB 
patients on drugs (0.18±0.90 Vs 0.17±0.86 µmol/L; 
P<0.05). Moreover, the mean value of  the free radicals 
was significantly higher in TB co-infection with HIV 
when compared with new cases TB patients and TB 
patients on drugs (0.30±1.45 Vs 0.27±0.08, 0.17±0.86 
µmol/L; P<0.05). Also, the mean value of  the free rad-
icals of  new cases TB patients was significantly higher 
when compared with TB patients on drugs (0.27±0.08 
Vs 0.17±0.86 µmol/L; P<0.05), table 5.
Table II showed the Pearson’s correlation of  TB pa-
tients co-infected with HIV. It showed a positive corre-
lation between sodium and chloride (r=0.979, P<0.01), 
sodium and free radicals (r=0.767, P<0.01), and chlo-
ride and free radicals (r=0.785, P<0.01). There was also 
an inverse correlation between potassium and chloride 
(r=0.763, P<0.01), potassium and sodium (r=0.793, 
P<0.01) and potassium and free radicals (r=0.478, 
P<0.05).
Table 2: Pearson’s correlation table of tuberculosis co-infection with HIV patients. 
 




Na+ (mmol/L) 1 -.793** .979* -.109 .767** 
K+ (mmol/L) -.793** 1 -.763** .115 -.428* 
Cl- (mmol/L) .979** -.763** 1 -.306 .785** 
HCO3-(mmol/L) -.109 .115 -.306 1 -.220 
Free radicals 
(µmol/L) 
.767** -.478** .785* -.220 1 
  
  Discussion:
In this study, mean values of  MDA was significantly 
higher in various TB cases when compared with con-
trols.  This supports another study in which higher val-
ues of  MDA level were found in patients with active TB 
compared to healthy controls and the difference was 
statistically significant with P =0.001.14 In another re-
lated study, the concentration of  MDA was higher in 
cases with active TB and TB / HIV cases on treatment 
than in the control groups.15 In yet another study, serum 
MDA concentration as a measure of  lipid peroxidation 
reflecting the degree of  oxidative stress was reported to 
be significantly higher in patients with tuberculosis than 
in healthy subjects.16










p-value Level of 
significance 
Total subject 
population Vs control 
0.25±0.11 0.18±0.90 4.48 0.00 P<0.05 
New case TB Vs TB 
on drug  
  
0.27±0.08 0.17±0.86 2.66 0.02 P<0.05 
TB patients on drug 
Vs TB patients co-
infection with HIV. 
0.17±0.86 0.30±1.45 2.63 0.12 P<0.05 
New cases TB subject 
Vs TB co-infection 
with HIV patients. 
0.27±0.08 0.30±1.45 3.01 0.01 P<0.05 
TB co-infection with 
HIV Vs Control 
0.30±1.45 0.18±0.90 4.59 0.00 P<0.05 
New cases TB 
patients  Vs TB co-
infection with HIV 
0.27±0.08 0.30±1.45 3.01 0.01 P<0.05 
TB patients on drug 
Vs TB patients co-
infection with HIV 
0.17±0.86 0.30±1.45 2.63 0.12 P<0.05 
 
African Health Sciences Vol 15 Issue 4, December 20151259
The significantly higher level of  free radicals found 
in new case pulmonary tuberculosis patients, and TB 
co-infection with HIV can be attributed to the facts that 
mycobacterium induces ROS and RNI by activating 
phagocytes14-16 which promote tissue injury and inflam-
mation.  This further contributes to immunosuppres-
sion in HIV infected patients.17 The bearing influence 
on ROS and RNI1 compared to controls could be as 
a result of  possible loss of  electrolytes during exces-
sive sweating associated with TB, diarrhea and vomiting 
which are common with HIV and co-infection with TB 
and HIV disease.  In HIV/AIDS infection, there is the 
killing of  cells by virus, high grade pyrexia (causing the 
destruction of  cells) and therefore leading to develop-
ment of  lung fibrosis which may be a long term sequel 
of  pulmonary tuberculosis.18  
The observed lower significance in TB patients on drug 
than new case TB patients and TB co-infections with 
HIV could therefore be the effect of  Rifampicin on the 
phagocytic cells.19 The elevated electrolytes levels (most 
especially sodium and chloride) suggests the importance 
of  carrying out levels of  MDA and electrolytes during 
management of  active TB cases. This is to prevent oc-
currences of  water and electrolyte imbalance and the 
possible damaging effects of  free radicals. The inability 
of  this study to do a Polymerase Chain Reaction (PCR) 
or culture to differentiate between typical and atypi-
cal Mycobacteria due to resource constraints could be 
regarded as a limitation to this study. This could have 
given a differential diagnosis with the likelihood of  pre-
senting with similar symptoms. This is however not a 
main focus of  this research. In conclusion, reduced se-
rum MDA levels in tuberculosis patients on drugs sug-
gest a reduction in the levels of  free radical injury once 
treatment is commenced. Therefore serum free radical 
may be an index of  monitoring response to treatment 
in tuberculosis management. The use of  serum MDA 
level at regular intervals is hereby recommended as a 




The authors are grateful to the Medical Directors of  
participating hospitals, TB program Director, the Lab-
oratory Department of  LAUTECH, College of  Health 
Sciences as well as all patients who participated in the 
study.  
Conflict of  Interest: 
None among authors and institutions relevant to this 
manuscript 
Funding: 
No external funding was received towards the conduct 
of  this research. 
References
1. World Health Organization (WHO). Tuberculosis 
Fact sheet 2006; No 104 - Global and regional inci-
dence; October 2013. 
2.  Centers for Disease Control and Prevention. Plan 
to combat extensively drug-resistant tuberculosis: rec-
ommendations of  the Federal Tuberculosis Task Force. 
MMWR Recomm Rep, 2009; 58 (RR-3):1-43. 
3.  Reddy YN, Murthy SV, Krishna DR, Prabhakar MC. 
Role of  free radicals and antioxidants in TB patients, 
Indian Journal of  Tuberc. 2004;51:213-218
4. Cem EH, Yusuf  TR, Mustafa Cekmen. Serum lev-
els of  TNF-a , sIL-2R, IL-6,and IL-8 are increased and 
associated with elevated lipid peroxidation in patients 
with Behçet’s disease. Mediators of  Inflammation. 
2002;11:87–93.
5. Rook GA, Seah G, Ustianowski AM Tuberculosis 
immunology and vaccination. Eur Respir Journal, 2001; 
17:537-557. 
6.  Dong-Ho Shin, Sabrina S. Martinez, M , Parsons, DT, 
Jayaweera AC, and Marianna KB Relationship of  Oxi-
dative Stress with HIV Disease Progression in HIV/
HCV Co-infected and HIV Mono-infected Adults in 
Miami. Intl J Biosci Biochem Bioinforma. 2012; 2(3): 217–
223.  
7. Wild I, Seaman T, Hoal EG, Benade AJ, Van HPD. 
Total antioxidant levels are low during active TB and 
rise with anti-tuberculosis therapy .IUBMB Life, 2004; 
56(2):101 PubMed -6 
8.  Corbett EL, Watt CJ, Walker N. The growing burden 
of  tuberculosis: global trends and interactions with the 
HIV epidemic. Arch Intern Med, 2003; 163:1009-1021 
PubMed.
9. National Population Commission (NPC). Nigeria 
Demographic and Health Survey 2006. Preliminary re-
port of  the National Population Commission. Federal 
Republic of  Nigeria, Abuja, Nigeria 2006
10. National Agency for the Control of  HIV/AIDS 
(NACA) 2010. Prevalence of  HIV among Tuberculo-
sis and HIV co-infected clients. NACA Abuja Nigeria 
2010.
African Health Sciences Vol 15 Issue 4, December 2015     1260
11. Yagi K. A simple fluorometric assay for lipoperox-
ide in blood plasma. Biochem Med, 1976; 15:212–6 11.
12. Bhagat CJ, Garcia-Webb P,  Fletcher E, Beilby JP. 
Calculated vs measured plasma osmolalities revisited. 
Clinical Chemistry, 1984; 30(10):1703 PubMed -5 12. 
13. Skeggs LT, Hochstrasser HC. Colometric method 
of  chloride estimation. Clin.Chem, 1964; 10:918-920 Pu-
bMed  
14.  Dhia AT and Imad AJT.Antioxidant Status, C - re-
active protein and Iron Status in Patients with Pulmo-
nary Tuberculosis. Sultan Qaboos Univ. Med J. 2010;10(3): 
361 PubMed –369 
15. Van Doom HR, Claas EC, Templeton KE, van der 
Zanden AG, te Koppele vije A, de long MD,dankert 
J, Kijper EJ. Detection of  a point mutation associated 
with high level INH resistance in MTB by using real 
time technology PCR with 3 minor groove binder DNA 
probe.  J Clin.Microbiology, 2003;41:4630-35 PubMed  , 
16. Madebo T, Lindtjørn B, Aukrust P and Berge RK. 
Circulating antioxidants and lipid peroxidation prod-
ucts in untreated tuberculosis patients in Ethiopia. Am 
J Clin Nutr, 2003;78 (1): 117-122 
17.  Muller F, Svardal AM, Nordoy I, Berge RK, Aukrust 
P, Froland SS. Virological and immunological effects of  
antioxidant treatment in patients with HIV infection. 
Eur J Clin Invest, 2000; 30: 905-914 PubMed 
18.  Jack CI, Jackson MJ. Hind CR. Circulating markers 
of  free radical activity in patients with pulmonary tu-
berculosis. Tuber Lung Dis, 2004;75 : 132-137 PubMed.  
19. Yael YI, Azoulay-Alfaguter EB, Rifampin Inhibits 
Prostaglandin E2 Production and Arachidonic Acid Re-
lease in Human Alveolar Epithelial Cells  Antimicrobi-
als Agents Chemother. 2007; 51(12): 4225–4230.  
African Health Sciences Vol 15 Issue 4, December 20151261
